These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment with cytosine arabinoside and granulocyte colony-stimulating factor in patients with myelodysplastic syndrome and its leukemic phase. Im T, Yamane T, Mugitani A, Hiyoshi M, Park K, Tatsumi N. Int J Hematol; 1994 Oct; 60(3):215-23. PubMed ID: 7532031 [Abstract] [Full Text] [Related]
4. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Greenberg P, Negrin R, Nagler A, Vincent M, Donlon T. Int J Cell Cloning; 1990 Jan; 8 Suppl 1():293-300; discussion 300-2. PubMed ID: 1691248 [Abstract] [Full Text] [Related]
5. [Clinical study of rhG-CSF (KRN8601) in patients with myelodysplastic syndrome]. Toyama K, Ohyashiki J, Takaku F, Kobayashi Y, Miyazono K, Miura Y, Sakamoto S, Mizoguchi H, Hoshino S, Urabe A. Rinsho Ketsueki; 1990 Jul; 31(7):937-45. PubMed ID: 1699007 [Abstract] [Full Text] [Related]
6. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, Sheay W, Cody R, Philipp C, Resta D, George M. Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235 [Abstract] [Full Text] [Related]
7. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI. Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020 [Abstract] [Full Text] [Related]
11. Sequential changes in stem cell markers in peripheral blood and leukapheresis samples after injections of recombinant human granulocyte colony-stimulating factor in patients with urogenital malignant solid tumors: a preliminary study. Samma S, Momose H, Ozono S, Hirao Y, Okajima E, Morii T, Nishikawa K, Shimoyama T, Fujimura Y. Jpn J Clin Oncol; 1994 Oct; 24(5):269-74. PubMed ID: 7526017 [Abstract] [Full Text] [Related]
12. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A. Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938 [Abstract] [Full Text] [Related]
13. [A successful case of congenital agranulocytosis treated with recombinant human granulocyte colony-stimulating factor]. Shimokawa T, Suzue T, Matsutomo S, Okabe K, Toki H. Rinsho Ketsueki; 1990 Oct; 31(10):1694-7. PubMed ID: 1701502 [Abstract] [Full Text] [Related]
14. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors. Berger C, Bertz H, Schmoor C, Behringer D, Potthoff K, Mertelsmann R, Finke J. Bone Marrow Transplant; 1999 May; 23(10):983-90. PubMed ID: 10373062 [Abstract] [Full Text] [Related]
16. [Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia]. Yamato H, Yamada K, Koike T, Yoshida M, Tsunogake S, Aoyagi M, Nakamura Y, Watanabe K, Saito K, Enokihara H. Rinsho Ketsueki; 1995 Feb; 36(2):128-33. PubMed ID: 7536277 [Abstract] [Full Text] [Related]
17. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Remacha AF, Arrizabalaga B, Villegas A, Manteiga R, Calvo T, Julià A, Fernández Fuertes I, González FA, Font L, Juncà J, del Arco A, Malcorra JJ, Equiza EP, de Mendiguren BP, Romero M. Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205 [Abstract] [Full Text] [Related]
18. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782 [Abstract] [Full Text] [Related]
19. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor. Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S. Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959 [Abstract] [Full Text] [Related]
20. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G. Haematologica; 1997 Jun 15; 82(3):291-6. PubMed ID: 9234574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]